Aridis Pharmaceuticals Inc (NASDAQ:ARDS)

1.01
Delayed Data
As of May 24
 0.00 / 0.00%
Today’s Change
0.88
Today|||52-Week Range
7.72
-56.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-8.2M-8.4M-24.7M-22.1M
 
 
 
 
 
Depreciation27.0K23.0K62.0K283.0K
 
 
 
 
 
Total Other Cash Flow2.8M1.4M6.8M66.0K
 
 
 
 
 
Funds From Operations-5.4M-7.0M-17.8M-21.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-921.0K-909.0K-277.0K2.5M
 
 
 
 
 
Net Cash Flow - Operating Activities-4.5M-6.1M-17.6M-24.3M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-1.0M
 
 
Capital Expenditures-1.0K-15.0K-698.0K-677.0K
 
 
 
 
 
Net Cash Flow Investing-1.0K-15.0K-698.0K-1.7M
 
 
 
 
 
 
FinancingShort Term Borrowings3.7M-300.0K0.000.00
 
 
 
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale89.0K25.8M21.1M25.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing3.8M25.5M21.1M25.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-738.0K19.4M2.8M-859.0K